#156518

Anti-Human cardiac troponin I (cTnI) scFv (4G5) [4G5scFv]

Cat. #156518

Anti-Human cardiac troponin I (cTnI) scFv (4G5) [4G5scFv]

Cat. #: 156518

Unit size: 100 ug

Availability: 10-12 weeks

Target: Human cardiac troponin I

Class: Recombinant

Application: ELISA ; IP ; WB

Host: Chicken

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Paul Conroy ; Caroline Murphy

Institute: Dublin City University

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-Human cardiac troponin I (cTnI) scFv (4G5) [4G5scFv]
  • Alternate name: cTnI
  • Class: Recombinant
  • Conjugation: Unconjugated
  • Host: Chicken
  • Application: ELISA ; IP ; WB
  • Description: Cardiac Troponin I and T are proteins of the sarcomeric pool, widely recognised as the gold standard biomarkers for AMI diagnosis. The biomarkers also impact the patient prognosis, risk stratification and guide therapeutic intervention. The cardiac troponins (cTn) are markers of myocyte necrosis and take several hours to reach peak elevation after the onset of ischemia.
  • Immunogen: TBC
  • Immunogen uniprot id: TBC

Target Details

  • Target: Human cardiac troponin I
  • Target background: Cardiac Troponin I and T are proteins of the sarcomeric pool, widely recognised as the gold standard biomarkers for AMI diagnosis. The biomarkers also impact the patient prognosis, risk stratification and guide therapeutic intervention. The cardiac troponins (cTn) are markers of myocyte necrosis and take several hours to reach peak elevation after the onset of ischemia.

Applications

  • Application: ELISA ; IP ; WB

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Shipping at 4° C

References

  • Conroy, P.J. (2011) Exploiting novel antibodies for the early detection of cardiac disease. PhD thesis, Dublin City University.